未登录

C

Chenjin Jin

sun yat sen university

H指数:23

被引数:2,049

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Natural Polysaccharide Microspheres for Ocular Drug Delivery: Sources, Design Strategies, and Therapeutic Applications

天然多糖微球在眼用药物递送中的应用：来源、设计策略及治疗应用

Asian Journal of Pharmaceutical Sciences

IF11.9

2026-09-010

OAAI

Subthreshold micropulse laser and conventional subthreshold laser in diabetic macular edema

阈值下微脉冲激光与常规阈值下激光在糖尿病黄斑水肿中的应用

Photodiagnosis and Photodynamic Therapy

IF2.6

2026-08-010

PRE

Novel OCT Angiography Parameters for Analyzing Microvascular Changes in Proliferative Diabetic Retinopathy After Intravitreal Conbercept Loading Injections

Photodiagnosis and Photodynamic Therapy

IF2.6

2026-01-160

OAAI

The mechanism and clinical effects of Q-Switched Nd:YAG laser membranotomy for treatment of macular pre-retinal hemorrhage: Case series and literature review

Q-Switched Nd:YAG激光膜切开术治疗黄斑前视网膜出血的机制与临床效果：病例系列与文献综述

OPTICS AND LASER TECHNOLOGY

IF5

2025-06-010

PRE

Comparison of photodynamic therapy with two different parameters combined with subconjunctival injection of bevacizumab for corneal neovascularization

PHOTODIAGNOSIS AND PHOTODYNAMIC THERAPY

IF2.6

2024-04-010

OAAI

A randomized non-inferiority trial of 577nm subthreshold micropulse laser versus half-dose photodynamic therapy for acute central serous chorioretinopathy

PHOTODIAGNOSIS AND PHOTODYNAMIC THERAPY

IF2.6

2024-02-012

OAAI

Long-Term Real-World Outcomes of Corneal Changes in Proliferative Diabetic Retinopathy: Panretinal Photocoagulation vs. Intravitreal Conbercept

PHOTODIAGNOSIS AND PHOTODYNAMIC THERAPY

IF2.6

2023-12-010

PRE

Application of Artificial Intelligence in Precision Medicine for Diabetic Macular Edema

ASIA-PACIFIC JOURNAL OF OPHTHALMOLOGY

IF4.5

2023-09-019

OAAI

Changes of microstructure of central serous chorioretinopathy on OCT and its relationship with prognosis

PHOTODIAGNOSIS AND PHOTODYNAMIC THERAPY

IF2.6

2023-06-011

PRE

Twenty-year outcome in neovascular age-related macular degeneration treated with photodynamic therapy and intravitreal bevacizumab/ranibizumab injections: A case report

PHOTODIAGNOSIS AND PHOTODYNAMIC THERAPY

IF2.6

2023-06-012

PRE

Hyperreflective material serves as a potential biomarker of dyslipidemia in diabetic macular edema

PHOTODIAGNOSIS AND PHOTODYNAMIC THERAPY

IF2.6

2022-09-011

PRE

Clinical and Genetic Analysis of RDH12-Associated Retinopathy in 27 Chinese Families: A Hypomorphic Allele Leads to Cone-Rod Dystrophy

INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE

IF4.7

2022-08-2210

OAAI

Nomogram-based prediction of clinically significant macular edema in diabetes mellitus patients

ACTA DIABETOLOGICA

IF2.9

2022-06-245

PRE

Intravitreal injection of triptolide attenuates subretinal fibrosis in laser-induced murine model

IF8.3

2021-12-0115

PREAI

Quantitative evaluation of damage to retinal capillaries caused by half-dose and half-time photodynamic therapy with optical coherent tomographic angiography

PHOTODIAGNOSIS AND PHOTODYNAMIC THERAPY

IF2.6

2021-12-015

PREAI

Predicting Central Serous Chorioretinopathy Recurrence Using Machine Learning

FRONTIERS IN PHYSIOLOGY

IF3.4

2021-11-255

OAAI

Comparison of the Effect of Pan-Retinal Photocoagulation and Intravitreal Conbercept Treatment on the Change of Retinal Vessel Density Monitored by Optical Coherence Tomography Angiography in Patients with Proliferative Diabetic Retinopathy

JOURNAL OF CLINICAL MEDICINE

IF2.9

2021-09-296

OAAI

Quantitative evaluation of photoreceptor density in chronic central serous chorioretinopathy using the Spectralis High Magnification Module

PHOTODIAGNOSIS AND PHOTODYNAMIC THERAPY

IF2.6

2021-09-014

PREAI

Subthreshold Micropulse Laser vs. Conventional Laser for Central Serous Chorioretinopathy: A Randomized Controlled Clinical Trial

FRONTIERS IN MEDICINE

IF3

2021-07-1616

OAAI

Triptolide-nanoliposome-APRPG, a novel sustained-release drug delivery system targeting vascular endothelial cells, enhances the inhibitory effects of triptolide on laser-induced choroidal neovascularization

BIOMEDICINE & PHARMACOTHERAPY

IF7.5

2020-11-0122

OAAI